Trading Signals: CYDY Stock Price Prediction and Forecast (Tue. Jul. 21, 2020 - Tue. Feb. 14, 2023)(CytoDyn Inc. )
| CYDY latest price $6.2400 (-7.56%) ($6.1500 - $6.3900) on Fri. Feb. 5, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 15.34% (three month average) | RSI | 0 | Latest Price | $6.2400(-7.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CYDY advances 5.8% a day on average for past five trading days. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CYDY advance at 0% a week (0% probability) SPLV(30%) SLV(26%) SIL(20%) SKYY(7%) SMH(-6%) | Factors Impacting CYDY price | CYDY will decline at least -7.67% in a week (0% probabilities). XRT(19%) IDRV(-35%) INDA(29%) IWD(-23%) IBB(-12%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -7.67% (StdDev 15.34%) | Hourly BBV | 0 () | Intraday Trend | -1.6% | | | |
|
5 Day Moving Average | $5.82(7.22%) | 10 Day Moving Average | $5.35(16.64%) | 20 Day Moving Average | $5.15(21.17%) | To recent high | -7.6% | To recent low | 21.4% | Market Cap | $3.238b | | | | CytoDyn, Inc. is a clinical-stage biotechnology company, which engages in the development of innovative treatments for multiple therapeutic indications based on leronlimab. Its product include HIV, cancer, graft-versus-host disease (GVHD), and PCa test. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA. |